Free Consultation: (800) 228-9159Tap to Call This Lawyer
Badges
Claimed Lawyer ProfileLII GoldBlawg Search
Practice Areas
- Personal Injury
- Animal & Dog Bites, Brain Injury, Car Accidents, Construction Accidents, Motorcycle Accidents, Premises Liability, Truck Accidents, Wrongful Death
- White Collar Crime
- Employment Law
- Employee Benefits, Employment Contracts, Employment Discrimination, ERISA, Overtime & Unpaid Wages, Sexual Harassment, Whistleblower, Wrongful Termination
- Medical Malpractice
- Birth Injury, Medical Misdiagnosis, Pharmacy Errors, Surgical Errors
- Products Liability
- Drugs & Medical Devices, Motor Vehicle Defects, Toxic Torts
Fees
- Free Consultation
Jurisdictions Admitted to Practice
- District of Columbia
- District of Columbia Bar
-
- Georgia
-
- 5th Circuit
-
- 11th Circuit
-
- United States District Court for the Northern District of Georgia
-
Languages
- English
Professional Experience
- Partner
- Finch McCranie, LLP
- - Current
Education
- Emory University
- J.D. (1977) | Law
-
- Harvard University
- A.B. (1974)
-
Awards
- Georgia’s Super Lawyers
- Super Lawyers
- 2005, 2006
Professional Associations
- District of Columbia Bar
- Member
- - Current
-
- Georgia State Bar
- Member
- - Current
-
Websites & Blogs
- Website
- Steven R. Wisebram's Website Profile
- Website
- Finch McCranie, LLP Website
- Website
- Steven R. Wisebram Whistleblower Website Profile
- Blog
- Trial Attorney Blog
- Opioid Prescriptions, Prosecution of Physicians, and the Mens Rea Dividing Line
July 19, 2022 - When a Privileged Conversation Isn’t: The Crime-Fraud Exception to Attorney-Client Privilege
July 6, 2021 - “Extra Icing on a Cake Already Frosted”: The Supreme Court’s Continuing Concern with Overcriminalization
June 7, 2021
- Blog
- Whistleblower Lawyer Blog
- COVID-19 Government Spending Must Be Protected by Whistleblowers–Through the False Claims Act and State False Claims Acts
August 11, 2022 - SEC Targets COVID-19 Fraud, and Its Success Will Depend on SEC Whistleblowers
June 23, 2020 - $465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products
August 18, 2017
Social Media
Contact & Map
There are no recently viewed profiles.
There are no saved profiles.
There are no profiles to compare.
